Since chronic colitis is a significant risk factor for development of CRC, we investigated whether myeloid-ILK deficiency ameliorates the colitis-associated cancer (CAC) model, also known as the AOM/DSS model (31). This evidence concerns the gene ILK and colorectal carcinoma.